GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (OTCPK:CLSH) » Definitions » Altman Z2-Score

CLS Holdings USA (CLS Holdings USA) Altman Z2-Score : -53.22 (As of Jun. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is CLS Holdings USA Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

CLS Holdings USA has a Altman Z2-Score of -53.22, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for CLS Holdings USA's Altman Z2-Score or its related term are showing as below:

CLSH' s Altman Z2-Score Range Over the Past 10 Years
Min: -3778.55   Med: -44.69   Max: -2
Current: -53.22

During the past 11 years, CLS Holdings USA's highest Altman Z2-Score was -2.00. The lowest was -3778.55. And the median was -44.69.


CLS Holdings USA Altman Z2-Score Historical Data

The historical data trend for CLS Holdings USA's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Altman Z2-Score Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.55 -26.28 -32.95 -28.18 -50.10

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.95 -50.10 -49.41 -44.69 -53.22

Competitive Comparison of CLS Holdings USA's Altman Z2-Score

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Altman Z2-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Altman Z2-Score falls into.



CLS Holdings USA Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

CLS Holdings USA's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*-1.0306+3.26*-12.5975+6.72*-0.7231+1.05*-0.5025
=-53.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Feb. 2024:
Total Assets was $9.13 Mil.
Total Current Assets was $4.12 Mil.
Total Current Liabilities was $13.53 Mil.
Retained Earnings was $-115.02 Mil.
Pre-Tax Income was -3.922 + -0.846 + 0.016 + -3.608 = $-8.36 Mil.
Interest Expense was -0.248 + -0.411 + -0.457 + -0.642 = $-1.76 Mil.
Total Liabilities was $20.65 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(4.122 - 13.531)/9.13
=-1.0306

X2=Retained Earnings/Total Assets
=-115.015/9.13
=-12.5975

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-8.36 - -1.758)/9.13
=-0.7231

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(-10.375 - 0)/20.645
=-0.5025

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

CLS Holdings USA has a Altman Z2-Score of -53.22 indicating it is in Distress Zones.


CLS Holdings USA  (OTCPK:CLSH) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


CLS Holdings USA Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (CLS Holdings USA) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Executives
Ross Silver director 516 SW 13TH STREET, SUITE 201, BEND OR 97702
Andrew Glashow director 1C BOWENS LANDING, NEWPORT RI 02840
Tribeca Investment Partners Pty Ltd 10 percent owner LEVEL 23, 1 O'CONNELL STREET, SYDNEY C3 2000
David Zelinger director C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Charlene Soco officer: Executive VP of Finance C/O CLS HOLDINGS USA, INC., 11767 SOUTH DIXIE HIGHWAY, SUITE 115, MIAMI FL 33156
Chetan Gulati 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Todd V Swanson 10 percent owner 10120 W. FLAMINGO ROAD, #4333, LAS VEGAS NV 89147
Gregg E. Carlson officer: Chief Financial Officer 2342 MALAGA PEAK STREET, LAS VEGAS NV 89135
Navy Capital Green Management Llc 10 percent owner, other: See Remark(1) 482 BAYBERRY LANE, MOUNTAINSIDE NJ 07092
Navy Capital Green Co-invest Partners Llc 10 percent owner, other: See Remark(1) 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Co-invest Fund, Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Management Partners Llc 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
John Kaden 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Sean Stiefel 10 percent owner 28 REICHERT CIRCLE, WESTPORT CT 06880
Navy Capital Green Fund, Lp 10 percent owner, other: See Remark(2) NAVY CAPITAL GREEN MANAGEMENT, LLC, 28 REICHERT CIRCLE, WESTPORT CT 06880